O N L I N E          L E T T E R S
women having “shared care” between their        can be first detected or predicted by testing
       OBSERVATIONS                              family doctors and the antenatal clinic, who    during pregnancy. Given these two major
                                                 would subsequently deliver in the public        considerations, it is reasonable to consider
                                                 hospital, and approximately one-half were       determining the percentage of women to be
Diagnosis                                        women who would be delivered in a pri-          diagnosed with GDM and adjusting the
of Gestational                                   vate hospital and attending one of several      diagnostic criteria accordingly.
                                                 private obstetricians. Women attending for
Diabetes Mellitus: A                             private pathology were older than women
Different Paradigm                               attending the public hospital.                                            NADIA MANZOOR, MD
                                                                                                                          ROBERT G. MOSES, MD
to Consider                                           With the IADPSG criteria compared
                                                 with the ADIPS criteria, the prevalence         From the Endocrine Registrar, Illawarra Shoalhaven
                                                 of GDM increased from 8.6 to 9.1% for             Local Health District, West Wollongong, New
T
                                                 antenatal clinic patients, from 10.5 to 16.2%     South Wales, Australia.
      he recently completed National In-         for private patients, and overall from 9.6      Corresponding author: Robert G. Moses, robert.
      stitutes of Health (NIH) (1) consen-       to 13.0%. This overall prevalence was sim-
                                                                                                   moses@sesiahs.health.nsw.gov.au.
      sus development conference on the                                                          DOI: 10.2337/dc13-1433
                                                 ilar to the 12.1 and 13.0% from a post hoc      © 2013 by the American Diabetes Association.
diagnosis of gestational diabetes mellitus       analysis of two Australian sites participat-      Readers may use this article as long as the work is
(GDM) found insufficient evidence to              ing in the HAPO study.                            properly cited, the use is educational and not for
change from current practice to that rec-             With an OR of 2.0, the glucose               profit, and the work is not altered. See http://
ommended by the American Diabetes As-                                                              creativecommons.org/licenses/by-nc-nd/3.0/ for
                                                 tolerance test diagnostic values were fast-       details.
sociation (2). The NIH final statement            ing $5.3 mmol/L, 1 h $10.6 mmol/L,
identified some key research gaps, the            and 2 h $9.0 mmol/L (5). The prevalence
first mentioned of which was to “evaluate         of GDM with these criteria was 5.6% for
the diagnostic thresholds associated with                                                        Acknowledgments—No potential conflicts of
                                                 antenatal clinic patients, 8.4% for private     interest relevant to this article were reported.
an odds ratio (OR) for adverse outcomes          patients, and 7.1% overall. Whereas with           N.M. researched the data. N.M. and R.G.M.
of 2.0 in the [Hyperglycemia and Adverse         an OR of 1.75, in our predominantly Cau-        wrote the manuscript. R.G.M. is the guarantor
Pregnancy Outcomes] HAPO study (as               casian population, 57% of women would           of this work and, as such, had full access to all
opposed to the OR of 1.75 that is                have been diagnosed based on the fasting        the data in the study and takes responsibility
currently recommended by the Interna-            glucose alone, this reduced to 33.7% with       for the integrity of the data and the accuracy of
tional Association of Diabetes in Preg-          an OR of 2.0.                                   the data analysis.
nancy Study Groups [IADPSG]).” We                     The strengths of the original study
currently have data that may assist in           were that it was prospective and included       c c c c c c c c c c c c c c c c c c c c c c c c
this consideration.                              women attending both the public hospital        References
     The results herein reported are from a      and the offices of private obstetricians.        1. National Institutes of Health Consensus
post hoc analysis of a prospective study         Women attending privately were older               Development Conference. Final Statement
carried out in 2010 (3) to determine the prev-   and had a much higher prevalence of GDM,           on Diagnosing Gestational Diabetes Melli-
alence of GDM with the proposed IADPSG           presumably because of their increased              tus. Bethesda, MD, National Institutes of
(4) criteria compared with the prevalence        age. Determination of the true prevalence          Health, 10 May 2013
using the then existing Australian Diabetes      of GDM in a community or country must           2. American Diabetes Association. Standards
in Pregnancy Society (ADIPS) criteria.           consider all of the health care delivery           of medical care in diabetes—2011. Diabetes
     Briefly, this study was carried out in a     options. Using an OR of 2.0 will reduce            Care 2011;34(Suppl. 1):S11–S61
city where all pregnant women are re-            the prevalence of GDM, compared with            3. Moses RG, Morris GJ, Petocz P, San Gil F,
quested to have a diagnostic 75-g glucose        using an OR of 1.75, and shift the di-             Garg D. The impact of potential new diag-
tolerance test, in this case with samples        agnostic emphasis away from the fasting            nostic criteria on the prevalence of gesta-
fasting and at 1 and 2 h, at the end of the                                                         tional diabetes mellitus in Australia. Med
                                                 glucose value. In our community, use of an
                                                                                                    J Aust 2011;194:338–340
second trimester. There is a high compli-        OR of 2.0 would give the same approxi-          4. Metzger BE, Gabbe SG, Persson B, et al.;
ance with this request. Samples were             mate prevalence of GDM as would the                International Association of Diabetes &
collected for the first 6 months of 2010          older ADIPS criteria.                              Pregnancy Study Groups (IADPSG) Con-
from women attending the antenatal clinics            There is a continuum of risk for              sensus Panel Writing Group and the Hyper-
at the only public obstetric hospital (n 5       increasing glucose levels in pregnancy             glycemia & Adverse Pregnancy Outcome
571) and from women attending a major            and a variety of adverse pregnancy out-            (HAPO) Study Steering Committee. The di-
private pathology provider (n 5 704). Ap-        comes. There is also an increasing prev-           agnosis of gestational diabetes mellitus: new
proximately one-half of the women attend-        alence of diabetes and lesser degrees of           paradigms or status quo? J Matern Fetal Neo-
ing the private pathology provider were          glucose intolerance in the community that          natal Med 2012;25:2564–2569
care.diabetesjournals.org                                                                   DIABETES CARE, VOLUME 36, NOVEMBER 2013             e187